A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder

NCT04100096 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

332

Enrollment

INDUSTRY

Sponsor class

Conditions

Borderline Personality Disorder

Interventions

DRUG: Brexpiprazole
OTHER: Placebo

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.